Androgen Deficiency

Treatment options for male hypogonadism - Abstract

Published on Tuesday, 21 May 2013 15:45

Male hypogonadism is a common condition widely associated with the aging process.

Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: A randomised controlled study - Abstract

Published on Friday, 17 May 2013 12:40

OBJECTIVE: To evaluate the efficacy and safety of long-acting i.m. testosterone undecanoate (TU) in Malaysian men with testosterone deficiency (TD).

Prevalence of andropausal symptoms among Kuwaiti males - Abstract

Published on Thursday, 16 May 2013 14:49

Andropause is a syndrome that usually occurs during men's midlife.

Negative association between testosterone concentration and inflammatory markers in young men: A nested cross-sectional study - Abstract

Published on Wednesday, 15 May 2013 16:26

OBJECTIVE: Low grade systemic inflammation (LGSI) as well as androgen deficiency has in older men been associated with several pathologies, including cardiovascular disease (CVD).

Functional and nutritional state in elderly men with compensated hypogonadism - Abstract

Published on Wednesday, 08 May 2013 18:55

OBJECTIVES: There are few data investigating the relationship between compensated hypogonadism and functional and nutritional status of elderly individuals.

HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism - Abstract

Published on Thursday, 02 May 2013 17:26

Metabolic disorders and cardiovascular events are increased in hypogonadism.

Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-Month safety report - Abstract

Published on Tuesday, 30 April 2013 16:19

Hypogonadism, which is highly prevalent in men with sickle cell disease (SCD), affects quality of life and causes great morbidity.

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: A 1-year, randomized, placebo-controlled, dose-ranging study - Abstract

Published on Friday, 26 April 2013 08:38

Objective: We investigated the effects of oral testosterone undecanoate (TU) on bone mineral density (BMD), lean body mass (LBM) and body fat mass (BFM) in aging men with symptomatic testosterone deficiency (TD).

Is androgen therapy indicated in men with osteoporosis? - Abstract

Published on Thursday, 25 April 2013 10:24

Male osteoporosis is not rare, and its management is a public health issue.

Risks and benefits of testosterone therapy in older men - Abstract

Published on Wednesday, 24 April 2013 10:20

In young men (defined as age < 50 years) with classic hypogonadism caused by known diseases of the hypothalamus, pituitary or testes, testosterone replacement therapy induces a number of beneficial effects, for example, the development of secondary sex characteristics, improvement and maintenance of sexual function, and increases in skeletal muscle mass and BMD.

Page 1 of 12

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End